Description
The study shows that trafficking-defective variants reduce CSF sSorLA levels, but the mechanistic link between impaired trafficking and reduced proteolytic shedding is unexplained. Understanding this mechanism is critical for interpreting sSorLA as a biomarker and developing therapeutic interventions.
Gap type: unexplained_observation Source paper: Soluble SorLA in CSF, a novel biomarker to explore disrupted trafficking of SorLA protein in Alzheimer disease. (2025, Alzheimer’s research & therapy, PMID:40336092)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:44.436939+00:00”, “resolution_summary”: “Resolved by hypothesis h-7d24e096: CSF sTREM2 as Pharmacodynamic Biomarker for Therapeutic Window Identification. Supporting evidence includes debate sess_SDA-2026-04-13-gap-pubmed-20260410-145358-185db2c8_20260414-005137.”, “match_counts”: {“hypothesis_matches”: 3, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-7d24e096”, “title”: “CSF sTREM2 as Pharmacodynamic Biomarker for Therapeutic Window Identification”, “score”: 0.246, “reason”: “23 token overlaps; entity overlap: csf”, “analysis_id”: “SDA-2026-04-26-trem2-showcase”, “target_gene”: “sTREM2/membrane-TREM2/ADAM10”, “target_pathway”: null, “disease”: “neuroimmunology”, “composite_score”: 0.801, “confidence_score”: 0.8, “status”: “promoted”, “pubmed_evidence_ids”: [“34661615”, “38760857”, “39444037”, “40593718”, “41198899”]}, {“id”: “h-SDA-2026-04-26-gap-20260426-001521-03-csf-plasma-aqp4-polarization-index-as-a-novel-bi-3c3fec6b27”, “title”: “CSF/Plasma AQP4 Polarization Index as a Novel Biomarker of Astrocyte Glymphatic Failure in Early Neurodegeneration”, “score”: 0.239, “reason”: “5 token overlaps; entity overlap: csf”, “analysis_id”: “SDA-2026-04-26-gap-20260426-001521”, “target_gene”: “AQP4”, “target_pathway”: null, “disease”: null, “composite_score”: 0.7050000000000001, “confidence_score”: 0.498, “status”: “proposed”, “pubmed_evidence_ids”: [“24179313”, “27371494”, “30561329”, “30842439”, “34499128”]}, {“id”: “h-26353f7f59”, “title”: “Temporal order is subtype-specific rather than universal”, “score”: 0.228, “reason”: “4 token overlaps; entity overlap: sorl1”, “analysis_id”: “SDA-2026-04-25-gapdebate-e849205bca”, “target_gene”: “APOE, SORL1, NTRK1, BIN1, PICALM”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.73, “confidence_score”: 0.76, “status”: “proposed”, “pubmed_evidence_ids”: [“28894304”, “31367008”, “34815562”, “36348357”, “37086935”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-145358-185db2c8_20260414-005137”, “title”: “The study shows homozygous R136S fully rescues APOE4-driven pathology while heterozygous provides only partial protection, but the mechanistic basis for this gene dosage effect is unexplained. Understanding this mechanism is critical for developing therapeutic strategies that could mimic R136S protection.\n\nGap type: unexplained_observation\nSource paper: The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation. (2023, Nature neuroscience, PMID:37957317)”, “score”: 0.494, “reason”: “14 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-145358-185db2c8”, “quality_score”: 0.81, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0_task_9aae8fc5”, “title”: “The abstract mentions that pathological seeds have different characteristics and conformations, but the underlying molecular mechanisms that generate this diversity remain unclear. Understanding these mechanisms is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: Protein transmission in neurodegenerative disease. (2020, Nat Rev Neurol, PMID:32203399)”, “score”: 0.483, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2_20260416-033018”, “title”: “The abstract shows p53 is a central regulator of C9orf72-mediated neurodegeneration but doesn’t explain how poly(PR) specifically activates p53. Understanding this upstream trigger mechanism is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). (None, None, PMID:33482083)”, “score”: 0.483, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2”, “quality_score”: 0.61, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062202-c8c5a9a1_task_9aae8fc5”, “title”: “The abstract identifies APOE4 association with increased TDP-43 pathology but the mechanistic link is unexplained. This connection could reveal novel therapeutic targets since APOE4 is the strongest genetic risk factor for AD.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Pathology in Alzheimer’s Disease. (2021, Mol Neurodegener, PMID:34930382)”, “score”: 0.483, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062202-c8c5a9a1”, “quality_score”: 0.61, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88_20260413-225852”, “title”: “The study shows VCP-mutant astrocytes exhibit hypoxia response activation without actual hypoxia, but the mechanistic link between VCP dysfunction and HIF-1α stabilization remains unexplained. Understanding this connection is critical for developing targeted therapies that could prevent early pathogenic events in VCP-ALS.\n\nGap type: unexplained_observation\nSource paper: Hypoxic stress is an early pathogenic event in human VCP-mutant ALS astrocytes. (2026, Stem cell reports, PMID:41349534)”, “score”: 0.479, “reason”: “14 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88”, “quality_score”: 0.78, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}